The definitive benchmark for viral vector dealmaking
Viral vector partnering is driven by its role as a critical enabling technology for gene and cell therapies, with deal structures reflecting platform access, manufacturing capabilities, and technical expertise.This report provides a comprehensive and structured analysis of 450+ viral vector collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.
Establish a clear view of market standards
The report enables a precise understanding of how viral vector deals are structured in practice, allowing you to:
- Benchmark comparable transactions with confidence
- Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
- Define realistic market parameters
- Clear insight into how deal terms vary by vector type, application, and partner profile
- Support valuation and structuring decisions with evidence
- Ground internal discussions in real transaction data rather than assumptions
- Understand how leading companies approach dealmaking
- Visibility into partner behaviour and recurring deal structures across a platform-driven and capacity-constrained landscape
- Full visibility into deal structure and execution
This includes:
- Rights granted and retained
- Development and commercialization responsibilities
- Financial structures and payment triggers
- Key contractual provisions and protections
Designed for real-world BD and strategy use
The report is widely used to:
- Structure and benchmark platform and enabling technology transactions
- Prepare for negotiations with well-defined market context
- Evaluate licensing, manufacturing, and collaboration partners
- Support internal strategy with robust, defensible data
What’s included?
- 450+ viral vector collaboration and licensing deals
- Financial terms, including upfronts, milestones, and royalties where disclosed
- Fully searchable deal directory (by company, vector type, and application)
- Direct access to SEC-filed agreements and source documents
- Analysis of deal trends, key transactions, and active dealmakers
- A trusted, evidence-based reference for viral vector dealmaking
Table of Contents
Executive SummaryChapter 1 - IntroductionChapter 6 - Viral vector dealmaking by technology type
Chapter 2 - Trends in viral vector dealmaking
Chapter 3 - Leading viral vector deals
Chapter 4 - Most active viral vector dealmakers
Chapter 5 - Viral vector contracts dealmaking directory
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2A
- 2seventy bio
- 3T Biosciences
- 4D Molecular Therapeutics
- AavantiBio
- AAVnerGene
- Abbvie
- Abeona Therapeutics
- ABL Bio
- Abzena
- Academy of Military Medical Sciences (China)
- Accelerator for Technological Research in Genomic Therapies
- Adaptive Phage Therapeutics
- Advanced Biotherapeutics Consulting
- Adverum Biotechnologies
- Aevitas Therapeutics
- Affini-T Therapeutics
- Affinia Therapeutics
- AGC Biologics
- Akouos
- Alaunos Therapeutics
- Albumedix
- Alcyone Lifesciences
- Aldevron
- Alexion Pharmaceuticals
- Alpha Teknova
- Altheia Science
- Altimmune
- American Gene Technologies
- Amicus Therapeutics
- AmplifyBio
- AmpliPhi Biosciences
- Andelyn Biosciences
- Apertura Gene Therapy
- Applied DNA Sciences
- Applied Genetic Technologies
- Aptuit
- Armata Pharmaceuticals
- Aruvant Sciences
- Ascidian Therapeutics
- ASC Therapeutics
- Asimov
- Asklepios Biopharmaceutical
- Astellas Pharma
- Astellas Pharma US
- AstraZeneca
- Athebio
- Athenex
- Auburn University
- Audentes Therapeutics
- Autodesk
- Avance Biosciences
- Avantor
- AviadoBio
- Avid Bioservices
- Avista Therapeutics
- Avrobio
- Axovant Gene Therapies
- Axovia Therapeutics
- Azenta Life Sciences
- Bayer
- Baylor College
- Beacon Therapeutics
- Beam Therapeutics
- Benitec Biopharma
- Berkeley Lights
- Bespoke Gene Therapy Consortium
- Bharat Biotech
- Bicycle Therapeutics
- BioAnalysis
- BIOASTER
- BioComo
- Biogen
- Bioharmony Therapeutics
- BioInvent
- BioMarin Pharmaceutical
- Biomedical Advanced Research and Development Authority
- BiomX
- Bionic Sight
- BionX Medical Technologies
- Biophage Pharma
- Biotechnology and Biological Sciences Research Council (BBSRC)
- Biotheus
- BioVectra
- Bioverativ
- Bluebird Bio
- Boehringer Ingelheim
- Brammer Bio
- BriaCell Therapeutics
- BridgeBio Pharma
- Bristol-Myers Squibb
- Broad Institute
- Cabaletta Bio
- Calidi Biotherapeutics
- California Institute for Regenerative Medicine
- California Institute of Technology
- Calimmune
- CANbridge Pharmaceuticals
- Capsida Biotherapeutics
- Capsigen
- CARB-X
- Caring Cross
- Carisma Therapeutics
- CARsgen
- Casebia Therapeutics
- Case Western Reserve University
- Catalent
- Celgene
- Cell and Gene Therapy Catapult
- Cellares
- Cellevolve Bio
- Cellinfinity Bio
- Cell Mogrify
- Cell Point
- Center for Breakthrough Medicines
- Center for Genomic Regulation
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Cevec Pharmaceuticals
- Charles River Laboratories
- Children's Hospital Boston
- Children's Medical Research Institute
- City of Hope
- Clearside Biomedical
- Cleveland Clinic
- Coalition for Epidemic Preparedness Innovations
- Coave Therapeutics
- Cobra Biologics
- Codexis
- Cognate BioServices
- Columbia University
- ContraFect
- Cornell University
- CPI International
- CRISPR Therapeutics
- Crosswalk Therapeutics
- CSL
- CSL Behring
- Cure Genetics
- Curigin
- Cyagen Biosciences
- Cyprium Therapeutics
- Cystic Fibrosis Foundation
- Cytoo
- Cytovance Biologics
- Daiichi Sankyo
- Dartmouth College
- DCM
- Decibel Therapeutics
- Defense Health Agency (US)
- Denali Therapeutics
- Department of Defense
- Desktop Genetics
- Dimension Therapeutics
- DiNAQOR
- Dispatch Bio
- Dr. Reddy's Laboratories
- Duke University
- Dyno Therapeutics
- Editas Medicine
- Eikonoklastes Therapeutics
- ElevateBio
- Eligo Bioscience
- Eli Lilly
- Emory University
- EnBiotix
- Enesi Pharma
- Enlivex
- Ensoma
- Epicrispr Biotechnologies
- ERS Genomics
- Eunice Kennedy Shriver Institute of Child Health and Human Development
- Eureka Therapeutics
- Evox Therapeutics
- Exagen Diagnostics
- Exothera
- Expression Therapeutics
- F1 Oncology
- Federal Ministry of Education and Research (BMBF)
- Felix Biotechnology
- Ferring Pharmaceuticals
- Florabio
- Forcefield Therapeutics
- Forge Biologics
- Form Bio
- Fortrea
- Fortress Biotech
- Forty Seven
- Foundation Fighting Blindness
- Foundation to Fight H-ABC
- Freeline Therapeutics
- Fujifilm Diosynth Biotechnologies
- G-Con
- Gazi University
- GE Healthcare
- Gen9
- GeneCraft
- Genelux
- Genenta Science
- Genentech
- Generation Bio
- Generation Biotech
- Genethon
- Genetix Biotherapeutics
- Genezen
- GenKOre
- Genosera
- Genovis
- Genprex
- Gensaic
- GenScript Biotech
- GenScript ProBio
- GentiBio
- Genzyme
- GeoVax
- Gilead Sciences
- Ginkgo BioWorks
- GlycoBac
- Great Ormond Street Hospital (GOSH)
- Gritstone Bio
- GSK
- Gyroscope Therapeutics
- Hadassah Medical Center
- HaemaLogiX
- Hansa Biopharma
- Hebrew University of Jerusalem
- Homology Medicines
- Horizon Discovery
- Hunterian Medicine
- Iaso Therapeutics
- Icahn School of Medicine at Mount Sinai
- Ikarovec
- ImmunityBio
- ImmVira
- Imperial Innovations
- Imugene
- Indee Labs
- InnoBation
- Innovate UK
- InProTher
- Inscripta
- Institute of Child Health
- Institute of Neurodegenerative Diseases
- Intellia Therapeutics
- Interbiome
- International AIDS Vaccine Initiative
- Intralytix
- iNtRON Biotechnology
- Iveric Bio
- iVexSol
- Janssen Biotech
- Janssen Pharmaceuticals
- Jasper Therapeutics
- JCR Pharmaceuticals
- Jenner Institute
- Johns Hopkins University
- Johnson & Johnson
- Johnson & Johnson Innovation
- JSR
- Juno Therapeutics
- KaliVir Immunotherapeutics
- Kelonia Therapeutics
- Kinea Bio
- Kiromic Biopharma
- Kissei Pharmaceutical
- Kriya Therapeutics
- Kyverna Therapeutics
- Laboratory Corporation of America
- Lacerta Therapeutics
- Leiden University
- Leidos
- Lesaffre
- Les Laboratoires Servier
- Leukocare
- LEXEO Therapeutics
- Locus Biosciences
- LogicBio Therapeutics
- Lonza
- Lysogene
- Magenta Therapeutics
- Mammoth Biosciences
- Massachusetts Eye and Ear Infirmary
- Massachusetts General Hospital
- Matica Biotechnology
- Max-Delbruck Center for Molecular Medicine
- Mayo Clinic
- Mayo Clinical Ventures
- McMaster University
- Medac
- MediciNova
- MediGene
- MedImmune
- MeiraGTx
- Microsoft
- Mie University
- MilliporeSigma
- Minaris Regenerative Medicine
- Mirum Pharmaceuticals
- Mission Bio
- MolMed
- Morgenesis
- Mosaic ImmunoEngineering
- Mount Sinai Health System
- MSD
- Muscular Dystrophy Association
- Mustang Bio
- Myrtelle
- Nanommune
- NantKwest
- NantOmics
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Research Council Canada
- National Resilience
- National Science Foundation
- Nationwide Children’s Hospital
- Navega Therapeutics
- Navy Medical Research Centre
- NEC
- NecstGen
- Neuracle Genetics
- Neurimmune Therapeutics
- Neurochase
- Neurocrine Biosciences
- Neurophth Therapeutics
- NewBiologix
- Newsoara Biopharma
- Next Generation Manufacturing Canada
- Nippon Shinyaku
- Noga Therapeutics
- Northern RNA
- Northwestern University
- Novartis
- Novasep
- NYU Langone Medical Center
- Oculogenex
- OmniaBio
- Ophthotech
- Optieum Biotechnologies
- Opus Genetics
- Orchard Therapeutics
- Oregon Health Sciences University
- Oregon National Primate Research Center
- OSR Holdings
- Oswaldo Cruz Foundation (Fiocruz)
- Otsuka
- Ovid Therapeutics
- Oxford BioMedica
- Oxford Genetics
- Oxgene
- Oyster Point Pharma
- Pall Corporation
- Papyrus Therapeutics
- Paragon Bioservices
- Passage Bio
- Passport Food Safety Solutions
- PaxVax
- Perelman School of Medicine
- PersonGen BioTherapeutics
- Peter MacCallum Cancer Institute
- Pfizer
- Phagelux
- Pherecydes Pharma
- PlasmidFactory
- Plasticell
- Plowshare Therapies
- Polyplus Transfection
- Precigen
- Precision NanoSystems
- Precision Virologics
- Pregene Biopharma
- Prevail Therapeutics
- ProteoNic
- Provecs Medical
- PsiOxus Therapeutics
- Quell Therapeutics
- rAAVen Therapeutics
- Raiden Science Foundation
- Ray Therapeutics
- ReciBioPharm
- Regeneron Pharmaceuticals
- Regenxbio
- ReiThera
- Renova Therapeutics
- RenovoRx
- Rentschler Biotechnologie
- Rescue Hearing
- Resilience
- Reyon Pharmaceuticals
- Roche
- Rocket Pharmaceuticals
- Rokote Laboratories
- Russian Direct Investment Fund
- Rznomics
- Saint Louis University
- Sangamo Therapeutics
- Sanofi
- Santen Pharmaceutical
- Santhera Pharmaceuticals
- Sant Joan de Déu-Barcelona Children’s Hospital
- Sarepta Therapeutics
- Sartorius
- Sartorius Stedim Biotech
- SCTbio
- Seattle Children's Therapeutics
- Seattle Childrens Research Institute
- Selecta Biosciences
- Sensei Biotherapeutics
- Sensorion
- Shape Therapeutics
- SillaJen
- Sino Biological
- Siren Biotechnology
- Sirion Biotech
- Skyline Therapeutics
- Solid Biosciences
- Solve GNE
- SparingVision
- Spark Therapeutics
- SpliceBio
- SQZ Biotech
- St. Jude Children's Research Hospital
- Stanford University
- St Jude Medical
- StrideBio
- Summit Biosciences
- SunTerra Biotechnology
- Symbiosis
- Synpromics
- Takeda Pharmaceutical
- Tamid Bio
- Targovax
- Taysha Gene Therapies
- Terumo Blood and Cell Technologies
- Tetherex Pharmaceuticals
- Texcell
- TFF Pharmaceuticals
- The Native Antigen Company
- Theravectys
- Theriva Biologics
- Thermo Fisher Scientific
- Tianjin CanSino Biotechnology
- TILT Biotherapeutics
- Touchlight
- TransCode Therapeutics
- Transgene
- Trieza Therapeutics
- Tufts Medical Center
- Turnstone Biologics
- Twist Bioscience
- uBriGene Biosciences
- UCB
- UK Cystic Fibrosis Gene Therapy Consortium
- Ultragenyx Pharmaceuticals
- UMass Chan Medical School
- UniQure
- Univercells
- University of Basel
- University of California Berkeley
- University of California Los Angeles
- University of California San Francisco
- University of Chicago
- University of Edinburgh
- University of Florida
- University of Florida Research Foundation
- University of Helsinki
- University of Kansas
- University of Leeds
- University of Manchester
- University of Massachusetts
- University of Massachusetts Medical School
- University of Miami
- University of Minnesota
- University of North Carolina
- University of Oxford
- University of Pennsylvania
- University of Pennsylvania School of Veterinary Medicine
- University of Pittsburgh
- University of Texas Southwestern Medical Center
- University of Western Sydney
- Unleash Immuno Oncolytics
- US Army
- Vaccinex
- Vaccitech
- Valo Therapeutics
- Vaxalto Biotherapeutics
- Vectalys
- Vector BioMed
- VectorBuilder
- VectorY Therapeutics
- Verismo Therapeutics
- Vertex Pharmaceuticals
- VIB
- Vifor-Fresenius Medical Care Renal Pharma
- ViGeneron
- Viralgen
- Vir Biotechnology
- Virginia Commonwealth University
- Virica Biotech
- VIVEbiotech
- Vivet Therapeutics
- Voyager Therapeutics
- Vyriad
- Wageningen University
- Walter Reed Army Institute of Research
- Washington University in St Louis
- Weizmann Institute
- Westmead Institute for Medical Research
- WhiteLab Genomics
- WuXi Advanced Therapies
- Xyphos Biosciences
- Yale Cancer Center
- Yale University
- Yeda Research and Development Company
- Yposkesi
- Ziopharm Oncology
- ZipBio
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
